发明名称 CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY
摘要 This disclosure provides a cell-based assay for testing the potency of multispecific binding molecules which specifically bind a T-cell antigen and a target antigen for redirected T-cell-mediated cellular cytotoxicity. The assay uses the TALL-104 T-cell line as effector cells, and provides a sensitive, specific, and reproducible method for ensuring that purity, activity, and stability of multispecific binding molecule batches can be measured for development, clinical trials, and commercial marketing.
申请公布号 US2017089885(A1) 申请公布日期 2017.03.30
申请号 US201515126922 申请日期 2015.03.18
申请人 APTEVO RESEARCH AND DEVELOPMENT LLC 发明人 Blankenship John;Sewell Elaine;Lowe Richard
分类号 G01N33/50;C07K16/30;C07K16/32;C07K16/28 主分类号 G01N33/50
代理机构 代理人
主权项 1. A method of measuring the cytotoxic potential of a multispecific binding molecule comprising: a. contacting the multispecific binding molecule with an immortalized cytotoxic T-cell (CTL) effector cell, wherein the CTL effector cell is a TALL-104 cell (ATCC CRL 11386), and wherein the multispecific binding molecule specifically binds the CTL effector cell via a T-cell (TC) antigen binding domain; b. contacting the multispecific binding molecule with a target cell, wherein the target cell expresses a target antigen, and wherein the multispecific binding molecule specifically binds to the target cell via a target antigen binding domain; and c. determining the extent of specific target cell death upon formation of an effector cell-multispecific binding molecule-target cell complex, thereby determining the cytotoxic potential of the multispecific binding molecule.
地址 Seattle WA US